Beximco Pharmaceuticals Ltd

In 1976, Beximco Pharmaceuticals Ltd was established as a subsidiary of BEXIMCO Group founded by 2 brothers A.S.F Rahman and Salman F Rahman. During its early times, the company imported drugs from USA-based Upjohn and Germany-based Bayer. Later in 1980 through the Licensing Agreement, Beximco Pharma began manufacturing these drugs. Beximco is currently one of the leading pharmaceutical manufacturers and exporters in Bangladesh. The company specializes in manufacturing generic drugs such as Intravenous Fluids, Therapeutic Nutrition Products, and Active Pharmaceutical Ingredients or APIs. Currently, the company produces more than 300 generics in several therapeutic segments.

The most popular painkiller medicine in the country Napa is one of Beximco’s most sold products. The company is the third leading pharmaceutical manufacturer in Bangladesh with a market share of 8.39 percent in the domestic pharmaceutical sector. Beximco also exports products to more than 50 countries, including countries in the USA, European Union, Australia, and Canada. The company currently has more than 5,000 full-time employees.

Listed on the Dhaka Stock Exchange, Beximco’s total revenue generated in the fiscal year 2020-21 was more than BDT 2,949 crore, of which Tk 2,633 crore was domestic sales. Besides, the company exports more than Tk 312 crore worth of products. Beximco is also listed as the first company in Bangladesh to be listed on the Alternative Investment Market on the London Stock Exchange. Beximco Pharmaceuticals also holds an 85.22-percent stake in Nuvista Pharma Limited and a 54.6-percent stake in Sanofi Bangladesh Limited.

Rate this organization

Click on a star to rate it!

Average rating 3 / 5. Vote count: 1

No votes so far! Be the first to rate this post.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top